Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$111,205
-$1,092,320 QoQ
Shares Held
10,393
-90.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 131 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. KROS ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in KROS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,205 | 10,393 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,203,525 | 109,015 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $790,945 | 38,848 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $61 | 6 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $25,201 | 1,592 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $55,025,389 | 947,570 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,924,995 | 370,350 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $64,338,522 | 971,881 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,229,704 | 81,230 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,773,488 | 149,733 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,049,338 | 349,660 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,781,682 | 205,660 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,996,138 | 520,536 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,455,020 | 91,840 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $3,687,768 | 63,028 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,878,616 | 148,600 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,098,719 | 402,607 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $13,735,621 | 223,162 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,081,452 | 213,800 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,116,456 | 80,800 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,712,773 | 152,300 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||